A detailed history of Forum Financial Management, LP transactions in United Therapeutics Corp stock. As of the latest transaction made, Forum Financial Management, LP holds 1,258 shares of UTHR stock, worth $450,804. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,258
Previous 1,247 0.88%
Holding current value
$450,804
Previous $286,000 39.86%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$228.26 - $319.04 $2,510 - $3,509
11 Added 0.88%
1,258 $400,000
Q4 2023

Feb 07, 2024

BUY
$214.88 - $256.94 $27,289 - $32,631
127 Added 11.34%
1,247 $274,000
Q1 2022

May 16, 2022

BUY
$166.16 - $213.96 $11,963 - $15,405
72 Added 6.87%
1,120 $200,000
Q4 2021

Feb 18, 2022

BUY
$184.32 - $216.08 $193,167 - $226,451
1,048 New
1,048 $226,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.3B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Forum Financial Management, LP Portfolio

Follow Forum Financial Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Forum Financial Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Forum Financial Management, LP with notifications on news.